Alcyone Therapeutics Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 12

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $160M

  • Investors
  • 1

Alcyone Therapeutics General Information

Description

Developer of neural intervention technology designed to treat neurological conditions. The company's technology is based on an engineered combination of micro-fabrication technologies and advanced biomedical engineering, with a core product focus on targeted drug therapy and hydrocephalus, enabling patients with chronic neuropathological conditions to receive improved treatment.

Contact Information

Website
alcyonetx.com
Formerly Known As
Alcyone Lifesciences
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 116 John Street
  • Suite 300
  • Lowell, MA 01852
  • United States
+1 (978)
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Vertical(s)
Corporate Office
  • 116 John Street
  • Suite 300
  • Lowell, MA 01852
  • United States
+1 (978)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alcyone Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 07-Nov-2025 $160M Completed Generating Revenue
10. Later Stage VC (Series F) 03-Apr-2025 Completed Generating Revenue
9. Grant 31-Dec-2021 Completed Generating Revenue
8. Later Stage VC (Series E) 08-Jun-2021 Completed Generating Revenue
7. Debt - PPP 27-Apr-2020 Completed Generating Revenue
6. Later Stage VC (Series D) 17-Jan-2018 Completed Generating Revenue
5. Later Stage VC (Series C) 24-Dec-2015 Completed Generating Revenue
4. Early Stage VC (Series B) 13-Jan-2014 Completed Generating Revenue
3. Early Stage VC (Series A1) 20-May-2013 $1M $2.84M Completed Generating Revenue
2. Early Stage VC (Series A) 27-Mar-2012 $1.84M $1.84M Completed Generating Revenue
To view Alcyone Therapeutics’s complete valuation and funding history, request access »

Alcyone Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E-1
Series E
Series D
Series C
Series B
Series A1 1,678,429 $0.000001 6% $0.43 $0.43 1x $0.43 2.44%
Series A 3,834,881 $0.000001 6% $0.37 $0.37 1x $0.37 5.57%
To view Alcyone Therapeutics’s complete cap table history, request access »

Alcyone Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of neural intervention technology designed to treat neurological conditions. The company's technology is based
Drug Discovery
Lowell, MA
12 As of 2026

Germantown, MD
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alcyone Therapeutics Competitors (20)

One of Alcyone Therapeutics’s 20 competitors is Orgenesis, a Corporation company based in Germantown, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Orgenesis Corporation Germantown, MD
Neurogene Formerly VC-backed New York, NY
Psy Therapeutics Venture Capital-Backed Boston, MA
Voyager Therapeutics Formerly VC-backed Lexington, MA
Hua Medicine Formerly VC-backed Pudong, China
You’re viewing 5 of 20 competitors. Get the full list »

Alcyone Therapeutics Patents

Alcyone Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025249271-A1 Methods and compositions for retinal gene therapy Pending 02-Apr-2024
WO-2025212772-A1 Methods and compositions for retinal gene therapy Pending 02-Apr-2024
JP-2024519889-A Fluid delivery system and method of treatment Pending 19-May-2021
CA-3219514-A1 Fluid delivery systems and methods of treatment Pending 19-May-2021
WO-2022246042-A1 Fluid delivery systems and methods of treatment Inactive 19-May-2021 A61K31/713
To view Alcyone Therapeutics’s complete patent history, request access »

Alcyone Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alcyone Therapeutics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Harbor Light Capital Partners Venture Capital Minority
National Aeronautics and Space Administration Government
Pimlico Pond Investments Family Office Minority
RTW Investments Hedge Fund Minority
Thornapple River Capital Venture Capital Minority
To view Alcyone Therapeutics’s complete investors history, request access »

Alcyone Therapeutics FAQs

  • When was Alcyone Therapeutics founded?

    Alcyone Therapeutics was founded in 2010.

  • Where is Alcyone Therapeutics headquartered?

    Alcyone Therapeutics is headquartered in Lowell, MA.

  • What is the size of Alcyone Therapeutics?

    Alcyone Therapeutics has 12 total employees.

  • What industry is Alcyone Therapeutics in?

    Alcyone Therapeutics’s primary industry is Drug Discovery.

  • Is Alcyone Therapeutics a private or public company?

    Alcyone Therapeutics is a Private company.

  • What is the current valuation of Alcyone Therapeutics?

    The current valuation of Alcyone Therapeutics is .

  • What is Alcyone Therapeutics’s current revenue?

    The current revenue for Alcyone Therapeutics is .

  • How much funding has Alcyone Therapeutics raised over time?

    Alcyone Therapeutics has raised $71.8M.

  • Who are Alcyone Therapeutics’s investors?

    Harbor Light Capital Partners, National Aeronautics and Space Administration, Pimlico Pond Investments, RTW Investments, and Thornapple River Capital have invested in Alcyone Therapeutics.

  • Who are Alcyone Therapeutics’s competitors?

    Orgenesis, Neurogene, Psy Therapeutics, Voyager Therapeutics, and Hua Medicine are some of the 20 competitors of Alcyone Therapeutics.

  • When was Alcyone Therapeutics acquired?

    Alcyone Therapeutics was acquired on 07-Nov-2025.

  • Who acquired Alcyone Therapeutics?

    Alcyone Therapeutics was acquired by Biogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process